Q1 2020 financial results

 

On 6 May 2020 Novo Nordisk A/S announced financial results for the first three months of 2020.

Financial results material (available on announcement day):
• Financial results
• Downloadable financial data


Investor presentation (available on announcement day):

• Investor presentation


Q1 2020 conference call on Wednesday, 6 May 2020 (13.00 CET) 
• Webcast link
• Conference call presentation

To access the conference call, please call the following numbers:

Denmark:

UK and international:

USA:

+45 3544 5577 (conference code 29981114#)

+44 333 300 0804 (conference code 29981114#)

+1 631 913 1422 (conference code 29981114#)

 

Q1 2020 investor presentation conference call and webcast on Thursday, 7 May 2020 (13.00 CET)

• Webcast link
• Webcast presentation

To access the conference call, please call the following numbers:

Denmark:

UK and international:

USA:

+45 32720417 (conference code 8946579#)

+44 (0) 2071 928338 (conference code 8946579#)

+1 646 741 3167 (conference code 8946579#)

 

If you have any questions, you are welcome to contact Novo Nordisk Investor Relations: 

+45 3075 2175              Daniel Muusmann Bohsen
+45 3079 0301
              Valdemar Borum Svarrer
+45 3075 2253              Ann Søndermølle Rendbæk
+45 3079 4211              Mark Joseph Root       
+1 609 235 2989           Kristoffer Due Berg (US)